TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06118385

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BEN8744
Description: Formulated powder in capsule for oral administration. Supplied as filled Size 0 Swedish Orange capsule. Doses: 2mg, 10mg and 40mg.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BEN8744
Description: Formulated powder in capsule for oral administration. Supplied as filled Size 0 Swedish Orange capsule. Doses: 2mg, 10mg and 40mg.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BEN8744
Description: Formulated powder in capsule for oral administration. Supplied as filled Size 0 Swedish Orange capsule. Doses: 2mg, 10mg and 40mg.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BEN8744
Description: Formulated powder in capsule for oral administration. Supplied as filled Size 0 Swedish Orange capsule. Doses: 2mg, 10mg and 40mg.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BEN8744
Description: Formulated powder in capsule for oral administration. Supplied as filled Size 0 Swedish Orange capsule. Doses: 2mg, 10mg and 40mg.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BEN8744
Description: Formulated powder in capsule for oral administration. Supplied as filled Size 0 Swedish Orange capsule. Doses: 2mg, 10mg and 40mg.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BEN8744
Description: Formulated powder in capsule for oral administration. Supplied as filled Size 0 Swedish Orange capsule. Doses: 2mg, 10mg and 40mg.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BEN8744
Description: Formulated powder in capsule for oral administration. Supplied as filled Size 0 Swedish Orange capsule. Doses: 2mg, 10mg and 40mg.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BEN8744
Description: Formulated powder in capsule for oral administration. Supplied as filled Size 0 Swedish Orange capsule. Doses: 2mg, 10mg and 40mg.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BEN8744
Description: Formulated powder in capsule for oral administration. Supplied as filled Size 0 Swedish Orange capsule. Doses: 2mg, 10mg and 40mg.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BEN8744
Description: Formulated powder in capsule for oral administration. Supplied as filled Size 0 Swedish Orange capsule. Doses: 2mg, 10mg and 40mg.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BEN8744
Description: Formulated powder in capsule for oral administration. Supplied as filled Size 0 Swedish Orange capsule. Doses: 2mg, 10mg and 40mg.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Matching Placebo
Description: Formulated powder in capsule for oral administration. Supplied as filled Size 0 Swedish Orange capsule. Doses: 2mg, 10mg and 40mg.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Matching Placebo
Description: Formulated powder in capsule for oral administration. Supplied as filled Size 0 Swedish Orange capsule. Doses: 2mg, 10mg and 40mg.
Study: NCT05805423

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: bilateral superficial cervical plexus blocks and local wound infiltration
Description: 10mL bupivacaine at Erb's point bilaterally and 10mL 0.25% Bupicacaine at incision

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: placebo injection and local wound infiltration
Description: 10mL normal saline at Erb's point bilaterally and 10mL 0.25% Bupicacaine at incision
Study: NCT05532644

Intervention type: OTHER
Intervention: AD drugs
Description: AD drugs

Intervention type: OTHER
Intervention: AD drugs
Description: AD drugs
Study: NCT06430697

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: paracetamol administration
Description: Patient hospitalized in Intensive Care Unit with a continuous measurement of blood pressure with a catheter and who have an administration of paracetamol by intravenous or per os
Study: NCT04482140

Intervention type: DEVICE
Intervention: Genta-Foil resorb®
Description: Use of Genta-Foil resorb® to prevent adhesions in patients undergoing hand surgery
Study: NCT05534217

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: corneal debridement of corneal abrasion
Description: Surgical debridement for traumatic corneal epithelial abrasions

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: corneal debridement of corneal abrasion
Description: Surgical debridement for traumatic corneal epithelial abrasions
Study: NCT04875013

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Vestibular rehabilitation with dynamic posturography
Description: Rehabilitation exercises guided by an interactive display and measured by a footplate sensor
Study: NCT05118191

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: OOLER
Description: Following the baseline block (first four weeks), participants will use the OOLER device to power a cooling mattress pad each night during sleep for four weeks.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: EmbrWave
Description: Following the baseline block (first four weeks), participants will use the Embr Wave 2 device to provide pulsed warm sensations to the inner wrist each night during sleep for four weeks.
Study: NCT04809012

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: STI-3031
Description: STI-3031 is an anti-PD-L1 antibody
Study: NCT05110638

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SKX-16 (Luliconazole 10% Solution)
Description: SKX-16 (Luliconazole 10% Solution) will be applied to each toenail and periungual areas once daily for 29 days such that there is sufficient quantity of solution to treat all toenails. All ten toes will be treated regardless of whether affected. The applications will occur in the clinic and be applied by study personnel. The nails will remain exposed until the applied solution dries.
Study: NCT06408662

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: mindfulness-based intervention for tics (MBIT)
Description: Psychological intervention that focuses on cultivating awareness of urges to tic and developing a different relationship to those urges through meditation and other mindfulness practice

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: psychoeducation with relaxation and supportive therapy (PRST)
Description: Psychological Intervention that focuses on learning more about tics, practicing a range of strategies for coping with tics (e.g., relaxation, effective communication), and discussing challenges commonly experienced by individuals with tics.
Study: NCT06102096

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Culturally Adapted iCBT
Description: A culturally adapted iCBT targeting mild to moderate mental health problems among Arabic-speaking refugee and migrant youth.
Study: NCT05354817

Intervention type: DRUG
Group type: OTHER
Intervention: mFOLFIRINOX
Description: mFOLFIRINOX: - Oxaliplatin; Leucovorin; Irinotecan and 5-FU
Study: NCT05075330

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Opioid Use Disorder Stigma Reduction
Description: Billboards with destigmatizing language regarding opioid use disorder placed in the community.
Study: NCT06163911

Intervention type: DEVICE
Intervention: ECG
Description: Routine care 12-lead electrocardiogram

Intervention type: DEVICE
Intervention: ECG
Description: Routine care 12-lead electrocardiogram

Intervention type: DEVICE
Intervention: Echocardiography
Description: Routine care echocardiography
Study: NCT06378775

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Coronary Artery Bypass Graft
Description: Coronary Artery Bypass Graft

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Robotically-assisted minimally-invasive direct coronary artery bypass
Description: Robotically-assisted minimally-invasive direct coronary artery bypass

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Percutaneous Coronary Intervention
Description: Percutaneous Coronary Intervention
Study: NCT05919342

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: NT-proBNP
Description: Patients will undergo an NT-proBNP which will guide their future involvement within the study. Patients with an NT-proBNP of ≥125 pg/mL will undergo transthoracic echocardiogram along with a clinical assessment - any diagnosis of HF will result in patients undergoing referral for initiation of guideline directed medical therapy (for HF).
Study: NCT04778735

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Liver Transplantation
Description: Liver Transplantation is performed under spesific conditions to increase the life time of patients with liver diseases.
Study: NCT05903508

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Functional task training and functional therapy program
Description: Functional task training group this will receive walking and no walking activities

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Functional task training and functional therapy program
Description: Functional task training group this will receive walking and no walking activities

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Functional therapy program Group
Description: Functional therapy program Group this will receive goal directed training

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Functional therapy program Group
Description: Functional therapy program Group this will receive goal directed training
Study: NCT04801420

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VLA15
Description: a multivalent recombinant Outer Surface Protein A (OspA) based vaccine candidate

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VLA15
Description: a multivalent recombinant Outer Surface Protein A (OspA) based vaccine candidate

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Placebo
Description: PBS (Phosphate Buffered Saline)

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: PBS (Phosphate Buffered Saline)
Study: NCT06706388

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: nL-ATN1-002
Description: Personalized antisense oligonucleotide
Study: NCT05513326

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercises and education
Description: Exercises: 3 training sessions per week that will last for 30 minutes. Sessions will start with 5 minutes of activation (walking on a treadmill or cycling). Then, participants will be asked to complete 5 exercises targeting lower limb strengthening (time: 18 minutes) followed by 2 exercises designed to improve balance and 3 stretching exercises for the lower limb (time: 7 minutes).~Education: Two one-on-one sessions (during week 2 and week 4 assessments) during which participants will receive information directly related to LSS and NC using illustration and videos. Participants will also be invited to ask their questions.

Intervention type: OTHER
Group type: OTHER
Intervention: Education alone
Description: Education: Two one-on-one sessions (during week 2 and week 4 assessments) during which participants will receive information directly related to LSS and NC using illustration and videos. Participants will also be invited to ask their questions.
Study: NCT05754034

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: High flow oxygen
Description: humidified and heated oxygen delivered at high flow rates via nasal cannula, with protocol to target SpO2 90-94%
Study: NCT06163911

Intervention type: DEVICE
Intervention: Echocardiography
Description: Routine care echocardiography
Study: NCT05754034

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard flow oxygen
Description: oxygen delivered at standard flow rates via nasal cannula, facemask, or nonrebreather mask, with protocol to target SpO2 90-94%
Study: NCT04510714

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Image guided percutaneous microwave ablation
Description: Lung metastasis from sarcoma will be treated with microwave antennas (SOLERO) and Ablation System and microwave generators (Angiodynamics), with power settings of 35-45W and an average ablation time of 15 minutes (range 10-30 minutes). The ablation time will be recorded for all procedures. The manufacturer's recommendations will be observed in all cases, since it is assured that patients are able to tolerate the total ablation time.
Study: NCT05262075

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Online Mindfulness Resiliency Program
Description: An approximate 20 minute online mindfulness resiliency program offered 3/wk x 4 weeks.
Study: NCT05398367

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Galactagogue Supplement for Treatment of Low Milk Supply
Description: Participants will consume a commercially available dietary supplement on the market for augmentation of breast milk production in lactating women with low milk supply

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Galactagogue Supplement for Treatment of Low Milk Supply
Description: Participants will consume a commercially available dietary supplement on the market for augmentation of breast milk production in lactating women with low milk supply

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Galactagogue Supplement for Treatment of Low Milk Supply
Description: Participants will consume a commercially available dietary supplement on the market for augmentation of breast milk production in lactating women with low milk supply

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Galactagogue Supplement for Treatment of Low Milk Supply
Description: Participants will consume a commercially available dietary supplement on the market for augmentation of breast milk production in lactating women with low milk supply
Study: NCT06515587

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Lewis genotype detection reagent
Description: By evaluating the results of the Lewis gene test combined with the CA19-9 test, different subtypes of pancreatic cancer patients were differentiated to evaluate the prognosis
Study: NCT06086509

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Music
Description: Children were played music during computerized tomography.
Study: NCT06525285

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Connective tissue graft wall technique
Description: Harvested connective tissue graft will be placed over the exposed root surface like a wall to cover the gingival recession

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Connective tissue graft wall technique
Description: Harvested connective tissue graft will be placed over the exposed root surface like a wall to cover the gingival recession
Study: NCT05887869

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Telehealth solution
Description: Telehealth solution offered for nutrition education and breastfeeding support.
Study: NCT05077826

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: North Coast Medical Activadose II
Description: tES device model Activadose II (North Coast Medical, Morgan Hill, CA, USA) programed to deliver tES.

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: North Coast Medical Activadose II
Description: tES device model Activadose II (North Coast Medical, Morgan Hill, CA, USA) programed to deliver tES.
Study: NCT06094088

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Heated Yoga
Description: Heated yoga described in arm/group description

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Non-Heated Yoga
Description: Non-heated yoga described in arm/group description
Study: NCT06411717

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Microstructure lens A
Description: Subjects randomized to Trial Group A will be required to wear microstructural lens A (microstructural design type with low defocus ratio) for 12 months

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Microstructure lens B
Description: Subjects randomized to Trial B will be required to wear microstructural lens B (high defocus ratio microstructural design type) for 12 months

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control group
Description: Subjects randomized to the control group will be required to wear aspherical single-light lenses for 12 months
Study: NCT06419985

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 80mg Ketamine HCl Prolonged Release
Description: Administration of Ketamine HCl Prolonged Release - 80mg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 160mg Ketamine HCl Prolonged Release
Description: Administration of Ketamine HCl Prolonged Release - 160mg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Administration of Ketamine HCl Prolonged Release - 240mg
Description: Administration of Ketamine HCl Prolonged Release - 240mg
Study: NCT05565287

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: ultra early physiotherapy intervention
Description: * NBAS / NBO and GMs based guidelines in explaining neonatal signs into the NICU (lasting 15-30 minutes)~* NBAS / NBO and GMs based guidelines in explaining neonatal signs to parents, 1st neonatal assessment and intervention upon hospital discharge (lasting one hour)~* NBAS / NBO and GMs based guidelines in explaining neonatal signs to parents, 1st neonatal assessment and intervention every 15 to 20 days until the 3rd month of life (corrected age).
Study: NCT05549895

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: 8 mg intrathecally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupivacaine Hydrochloride
Description: 0.5 % intrathecally

Intervention type: DRUG
Group type: OTHER
Intervention: Bupivacaine Hydrochloride
Description: 0.5 % intrathecally
Study: NCT05555303

Intervention type: DRUG
Group type: OTHER
Intervention: Amikacin
Description: In addition to the all-oral RR-TB treatment, add two intramuscular doses each consisting of 30 mg amikacin/kg, a first dose on day 1 and a second dose on day 4, all in the first week of treatment.~The amikacin solution will be admixed with a lidocaine solution in the syringe before administration.
Study: NCT04935996

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pleuropulmonary echography
Description: Pleuropulmonary echography is performed, in addition of the chest X-ray already performed in routine care
Study: NCT05651282

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Provera
Description: Progesterone Challenge Test
Study: NCT06196385

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: intensive Cervical Traction
Description: A 30-minute cervical traction protocol, twice a day, for five consecutive days per week for 6 weeks. The main objective will be the evaluation of depression, insomnia, and quality of life. We evaluate at prior to the treatment and, at the end of the protocol, for depression, insomnia, and quality of life.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: intensive Cervical Traction
Description: A 30-minute cervical traction protocol, twice a day, for five consecutive days per week for 6 weeks. The main objective will be the evaluation of depression, insomnia, and quality of life. We evaluate at prior to the treatment and, at the end of the protocol, for depression, insomnia, and quality of life.
Study: NCT04870762

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Best Practice
Description: Receive standard of care

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Best Practice
Description: Receive standard of care

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Medical Device Usage and Evaluation
Description: Wear 3D printed oral stent

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Medical Device Usage and Evaluation
Description: Wear 3D printed oral stent
Study: NCT05787340

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Bilişsel Egzersiz Terapi Yaklaşımı (BETY, Cognitive Exercise Therapy Approach)
Description: Bilişsel Egzersiz Terapi Yaklaşımı (BETY, Cognitive Exercise Therapy Approach) is a group exercise method that conforms to the biopsychosocial model via telerehabilitation.
Study: NCT06343246

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training with device
Description: : A randomized, controlled three-arm study. Forty-five patients with HT randomized three group: Group 1 will receive IMT (7 days/8 weeks) with function and POWERbreathe® Classic LR device, group 2 will reviece only IMT with 50 % maximal inspiratory pressure (MIP), n: 15) and control group will recieve breathing exercises(7 days/8 weeks).

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training with device
Description: : A randomized, controlled three-arm study. Forty-five patients with HT randomized three group: Group 1 will receive IMT (7 days/8 weeks) with function and POWERbreathe® Classic LR device, group 2 will reviece only IMT with 50 % maximal inspiratory pressure (MIP), n: 15) and control group will recieve breathing exercises(7 days/8 weeks).

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Inspiratory muscle training with device
Description: : A randomized, controlled three-arm study. Forty-five patients with HT randomized three group: Group 1 will receive IMT (7 days/8 weeks) with function and POWERbreathe® Classic LR device, group 2 will reviece only IMT with 50 % maximal inspiratory pressure (MIP), n: 15) and control group will recieve breathing exercises(7 days/8 weeks).